Friday, September 4, 2026

Molina Healthcare Inc And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

January 4, 2021

Molina Healthcare Inc And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Leidos Holdings, Inc.

13.4% sales growth and 17.6% return on equity

Leidos Holdings, Inc. provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally.

Leidos Holdings, Inc.'s sales growth this year is anticipated to be 12.1% and 12.3% for next year.

Year-on-year quarterly revenue growth grew by 14.4%, now sitting on 12B for the twelve trailing months.

Leidos Holdings, Inc.'s sales growth for the next quarter is 13.4%. The company's growth estimates for the ongoing quarter and the next is 6.6% and 23.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.6%.

Volatility

Leidos Holdings, Inc.'s last day, last week, and last month's average volatility was a negative 1.15%, a positive 0.09%, and a positive 0.06%, respectively.

Leidos Holdings, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.01%, 1.85%, and 1.94%, respectively.

Leidos Holdings, Inc.'s Stock Yearly Top and Bottom Value

Leidos Holdings, Inc.'s stock is valued at $103.59 at 04:22 EST, way under its 52-week high of $125.84 and way higher than its 52-week low of $68.00.

Leidos Holdings, Inc.'s Moving Average

Leidos Holdings, Inc.'s worth is higher than its 50-day moving average of $102.23 and way higher than its 200-day moving average of $93.20.

2. Systemax Inc.

10.7% sales growth and 35.39% return on equity

Systemax Inc., through its subsidiaries, operates as a direct marketer of brand name and private label industrial and business equipment and supplies in North America.

Systemax Inc.'s sales growth this year is anticipated to be 7% and 5.5% for next year.

Year-on-year quarterly revenue growth grew by 17.1%, now sitting on 977.3M for the twelve trailing months.

Systemax Inc.'s sales growth for the next quarter is 10.7%. The company's growth estimates for the current quarter and the next is 43.3% and 76.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 35.39%.

Volatility

Systemax Inc.'s last day, last week, and last month's average volatility was a negative 1.01%, a negative 0.26%, and a positive 0.73%, respectively.

Systemax Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.32%, 2.14%, and 3.08%, respectively.

Systemax Inc.'s Stock Yearly Top and Bottom Value

Systemax Inc.'s stock is valued at $35.55 at 04:22 EST, under its 52-week high of $38.00 and way higher than its 52-week low of $14.00.

Systemax Inc.'s Moving Average

Systemax Inc.'s value is above its 50-day moving average of $33.19 and way higher than its 200-day moving average of $25.15.

3. Molina Healthcare Inc

25.4% sales growth and 40.03% return on equity

Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.

Molina Healthcare Inc's sales growth this year is anticipated to be 16.1% and 17.5% for next year.

Year-on-year quarterly revenue growth grew by 16%, now sitting on 17.66B for the twelve trailing months.

Molina Healthcare Inc's sales growth for the next quarter is 25.4%. The company's growth estimates for the present quarter and the next is a negative 45.8% and 23.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 40.03%.

Volatility

Molina Healthcare Inc's last day, last week, and last month's average volatility was 0.40%, 0.51%, and 0.01%, respectively.

Molina Healthcare Inc's last day, last week, and last month's high and low average amplitude percentage was 1.74%, 2.03%, and 2.61%, respectively.

Molina Healthcare Inc's Stock Yearly Top and Bottom Value

Molina Healthcare Inc's stock is valued at $206.63 at 04:22 EST, under its 52-week high of $224.00 and way above its 52-week low of $102.85.

Molina Healthcare Inc's Moving Average

Molina Healthcare Inc's value is under its 50-day moving average of $208.67 and higher than its 200-day moving average of $192.18.

4. HarborOne Bancorp, Inc.

16.3% sales growth and 4.65% return on equity

HarborOne Bancorp, Inc. operates as the holding company for HarborOne Bank that provides financial services to individuals, families, small and middle-market businesses, and municipalities.

HarborOne Bancorp, Inc.'s sales growth this year is anticipated to be 8.8% and 3.1% for next year.

Year-on-year quarterly revenue growth grew by 40.1%, now sitting on 207.3M for the twelve trailing months.

HarborOne Bancorp, Inc.'s sales growth for the next quarter is 16.3%. The company's growth estimates for the current quarter and the next is 200% and 100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.65%.

Volatility

HarborOne Bancorp, Inc.'s last day, last week, and last month's average volatility was a negative 0.28%, a negative 0.30%, and a positive 0.13%, respectively.

HarborOne Bancorp, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 1.40%, 2.80%, and 2.65%, respectively.

HarborOne Bancorp, Inc.'s Stock Yearly Top and Bottom Value

HarborOne Bancorp, Inc.'s stock is valued at $10.80 at 04:22 EST, below its 52-week high of $11.20 and way higher than its 52-week low of $6.45.

HarborOne Bancorp, Inc.'s Moving Average

HarborOne Bancorp, Inc.'s value is higher than its 50-day moving average of $10.34 and way above its 200-day moving average of $9.09.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com